RYM:NZXRyman Healthcare Ltd. Analysis
Data as of 2026-08-18 - not real-time
$21.33
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $21.33, RYTHM, Inc. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 11.0% over the past 30 days. RSI sits at 48.3, which reads as neutral, and MACD momentum is bullish. Watch $17.85 as support and $26.31 as the nearer resistance level.
Revenue is growing at 1027.4% on a -6.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 98.4%, a beta of 1.40 and a maximum drawdown of 69.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Revenue is growing at 1027.4% on a -6.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 98.4%, a beta of 1.40 and a maximum drawdown of 69.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
RYTHM, Inc. Reports Second Quarter 2026 Results. ROLLING MEADOWS, Ill., Aug. 04, 2026 GLOBE NEWSWIRE -- RYTHM, Inc....ROLLING MEADOWS, Ill., Aug. 04, 2026 GLOBE NEWSWIRE -- RYTHM, Inc. Nasdaq: RYM 'RYTHM” or the 'Company” ,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 22.97
- MACD momentum is positive
- 30-day price change of -11.0%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 22.97
- 30-day volatility of 98.4%
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -6.2%
- Negative return on equity of -10.5%
- Revenue growth of +1027.4%
Key Metrics & Analysis
Financial Health
Revenue Growth1027.40%
Profit Margin-6.21%
ROE-10.51%
ROA-8.90%
Debt/Equity206.27
P/B Ratio1.2
Op. Cash Flow$1.3M
Free Cash Flow$359.6K
Technical Analysis
TrendNeutral
RSI48.3
Support$17.85
Resistance$26.31
MA 20$20.84
MA 50$23.44
MA 200$22.97
MACDBullish
VolumeDecreasing
Fear & Greed Index93.46
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.40
Volatility98.40%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.